LGVN Stock Summary and Trading Ideas (Longeveron - Class A | NASDAQ:LGVN)

Longeveron Inc is a clinical stage biotechnology company developing regenerative medicines to address unmet medical needs. Its investigational product candidate is laromestrocel. Laromestrocel is a proprietary, scalable, allogeneic cellular therapy that has multiple potential modes of action that include pro-vascular, pro-regenerative, and anti-inflammatory mechanisms that collectively appear to promote tissue repair and healing. It is in clinical development of a single investigational product candidate, laromestrocel, for four potential indications: HLHS, Alzheimer's disease (AD), Pediatric Dilated Cardiomyopathy (pediatric DCM), and Aging-related Frailty. It operates in a single operating segment focused on developing regenerative medicines to address unmet medical needs.

Longeveron - Class A trades on the NASDAQ stock market under the symbol LGVN.

As of June 9, 2026, LGVN stock price climbed to $0.77 with 114,555 million shares trading.

LGVN has a beta of -0.49, meaning it tends to be less sensitive to market movements. LGVN has a correlation of 0.00 to the broad based SPY ETF.

LGVN has a market cap of $24.42 million. This is considered a Sub-Micro Cap stock.

Last quarter Longeveron - Class A reported $398,000 in Revenue and -$.19 earnings per share. This beat revenue expectation by $64,800 and met earnings estimates .

In the last 3 years, LGVN traded as high as $40.00 and as low as $.48.

The top ETF exchange traded funds that LGVN belongs to (by Net Assets): VTI, VXF.

LGVN has underperformed the market in the last year with a price return of -37.2% while the SPY ETF gained +24.3%. However, in the short term, LGVN had mixed performance relative to the market. It has outperformed in the last 3 months, returning +59.8% vs +9.9% return in SPY. But in the last 2 weeks, LGVN shares have been beat by the market, returning -5.8% compared to an SPY return of -1.2%.

LGVN support price is $.71 and resistance is $.80 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that LGVN shares will trade within this expected range on the day.